KLK3 and cancer: The specific use based on PSA-expressing exosomes (NSFC-exo) had a statistically significant (but relatively weak) correlation with exosome number, suggesting that the kind of ‘cancer-related’ information provided by both the size and number of exosomes is broadly independent of the specific (prostate) cancer type.